Meet the Journal Editors

Special Event

Date & Time:

February 15, 2026

12:00 PM – 1:00 PM PT

Format:

In Person

session objectives:

What You'll Learn

Meet the Editors of ASPEN’s journals at the ASPEN Bookstore!

Topics & Presenters

Kenneth B. Christopher
MD, MS

Editor-in-Chief, JPEN

American Society for Parenteral and Enteral Nutrition

Associate Physician

Division of Renal Medicine, Brigham and Women’s Hospital

Assistant Professor of Medicine

Division of Nutrition, Harvard Medical School

Boston, MA
Russell J. Merritt
MD, PhD

Editor-in-Chief, NCP

American Society for Parenteral and Enteral Nutrition

Founding Director, Intestinal Rehabilitation Program

Children's Hospital Los Angeles

Professor Emeritus of Pediatrics

Keck School of Medicine of USC

Los Angeles, CA

Innovation Theater: Blenderized Tube Feeds Real Talk: Myth-busting Whole Food Enteral Nutrition

Corporate Event

Date & Time:

February 16, 2026

9:45 AM – 10:30 AM PT

Format:

In Person

session objectives:

What You'll Learn

Curious about blenderized tube feeds? Come learn the truth behind common myths, see live demos, and walk away with actionable strategies for patient care.

 

This program is not accredited.

Topics & Presenters

Emily Miller
MBA, BSN, RN

Global Medical Advisor

Cardinal Health

Dublin, OH

Innovation Theater: Reimagining Enteral Tube Feeding Support in the Digital Age

Corporate Event

Date & Time:

February 15, 2026

12:45 PM – 1:30 PM PT

Format:

In Person

session objectives:

What You'll Learn

Topics

  • Building the Next Generation of Nutrition Clinicians: The CORTRAK Training Grant Program
  • Empowering Tube-Fed Patients at Home: Introducing the Nutrition Tracking App

 

This program is not accredited.

Innovation Theater: Real-World Evidence: Bridging the Gap Between Clinical Trials and Everyday Practice for Short Bowel Syndrome (SBS)

Corporate Event

Date & Time:

February 15, 2026

9:30 AM – 10:15 AM PT

Format:

In Person

session objectives:

What You'll Learn

  • Explore short bowel syndrome (SBS) from identification through diagnosis
  • Review nutritional management and weaning from parenteral support (PS)
  • Examine an evidence-based therapeutic approach for patients with SBS depending on PS

Topics & Presenters

Syed-Mohammed Jafri
MD

Professor of Medicine

Gastroenterology and Hepatology, Henry Ford Health System

Associate Program Director

Gastroenterology and Hepatology, Henry Ford Health System

Detroit, MI

Innovation Theater: Managing Hyperglycemia in Parenteral Nutrition

Corporate Event

Date & Time:

February 16, 2026

12:45 PM – 1:30 PM PT

Format:

In Person

session objectives:

What You'll Learn

Upon completion of this educational activity, the learner will be able to:

  • Define hyperglycemia and identify diagnostic criteria in hospitalized adults.
  • Describe complications and adverse outcomes associated with hyperglycemia.
  • Summarize ASPEN recommendations for glucose targets and PN prescribing.
  • Apply strategies to prevent and manage hyperglycemia in patients receiving PN.

 

This presentation is not accredited.

Topics & Presenters

Andrew Adorno
MS, RD-AP, LD, CNSC

Advanced Practice Clinical Dietitian III

Food and Nutrition Services, Harris Health System Ben Taub General Hospital

Houston, TX

Corporate Symposium: Addressing Choline Deficiency in Intestinal Failure: Clinical Implications and Management Strategies for Patients Dependent on Parenteral Support

Corporate Event

Date & Time:

February 15, 2026

7:30 PM – 9:00 PM PT

Format:

In Person

session objectives:

What You'll Learn

Dinner Buffet will be available beginning at 7:00PM.

Learning Objectives

At the conclusion of this session, participants will be able to:

  1. Identify the essential role of choline in human metabolism and recognize the prevalence of choline deficiency in patients dependent on parenteral support.
  2. Evaluate the clinical consequences of choline deficiency, particularly hepatic steatosis, cholestasis, and liver dysfunction, cognitive decline and impact on muscle function in pediatric and adult patients on parenteral support.
  3. Implement evidence-based strategies for assessing the use of choline in patients dependent on parenteral support.

 

Statement of Need/Rationale

Choline is an essential nutrient that is critical for cell membrane integrity, neurotransmitter synthesis, DNA repair, and lipid transport and metabolism. Despite its classification as an essential nutrient by the Institute of Medicine in 1998, choline is not included in parenteral nutrition formulations. Recent research indicates that 78% of patients dependent on parenteral support are choline-deficient, with 63% of these patients demonstrating liver dysfunction, including steatosis, cholestasis, and hepatobiliary injury. This underscores a significant gap in current clinical practice.

The American Society for Parenteral and Enteral Nutrition (ASPEN) has recommended that choline be should be included in parenteral support products; ASPEN has defined choline as critical for all infants requiring parenteral support, yet studies on parenteral choline administration in neonates and older children remain insufficient. Phosphatidylcholine and sphingomyelin, containing a choline headgroup, are constitutive membrane phospholipids accounting for >85% of total choline, indicating particularly high requirements during growth.

Currently there are no approved choline products in the US or globally for intravenous use as a source of choline. These patients are or may become choline deficient, which represents a significant unmet medical need for this population. Evidence has demonstrated that choline deficiency contributes to liver injury during dependence on parenteral support, and supplementation can ameliorate and possibly prevent this complication.

This educational session aims to address the need for greater awareness and understanding of the role of choline and choline deficiency in both pediatric and adult populations on parenteral support, with emphasis on assessment, prevention, and management strategies to improve patient outcomes.

Topics & Presenters

Welcome and Introduction

Jacqueline Zummo
PhD, MPH, MBA

Co-Founder, Senior Vice President, Chief R&D Officer

Protara Therapeutics

New York, NY

The Role of Choline in Human Metabolism and Consequences of Deficiency

Alan L. Buchman
MD, MSPH

Professor of Clinical Surgery (Gastroenterology)

University of Illinois at Chicago/UI Health

Medical Director

Intestinal Rehabilitation and Transplant Center

Chicago, IL

Choline Deficiency in Parenteral Support: Evidence, Assessment, and Management

Paul Wischmeyer
MD, EDIC, FCCM, FASPEN

Professor of Anesthesiology and Surgery; Director, TPN/Nutrition Support Service

Duke University School of Medicine

Associate Vice Chair for Clinical Research

Department of Anesthesiology, Duke University School of Medicine

Durham, NC

Pediatric Perspectives: Addressing Choline Deficiency in Parenteral Nutrition for Children

Samuel Kocoshis
Samuel Kocoshis
MD

Professor of Pediatrics

University of Cincinnati College of Medicine, Cincinnati Children's Hospital Medical Center

Medical Director

Intestinal Transplantation, University of Cincinnati College of Medicine, Cincinnati Children's Hospital Medical Center

Director Emeritus

Intestinal Rehabilitation, University of Cincinnati College of Medicine, Cincinnati Children's Hospital Medical Center

Cincinnati, OH

New Developments in the Use of Choline During Parenteral Nutrition

Palle Bekker Jeppesen
MD, PhD

Associate and Clinical Professor

Department of Digestive Diseases, Transplantation, and General Surgery, Rigshospitalet University of Copenhagen

Copenhagen, Hovedstaden, Denmark

Corporate Symposium: From Myth to Mastery: Translating Evidence into Practice in Pediatric Parenteral Nutrition (SYMP5)

Corporate Event

Date & Time:

February 17, 2026

6:00 AM – 7:30 AM PT

Format:

In Person & Virtual

Pediatric Content Included

session objectives:

What You'll Learn

  • Challenge misconceptions and promote evidence-based use of injectable lipid emulsions in clinical practice.
  • Correct assumptions about PN stability and the effects of light and oxygen on nutrient integrity.
  • Address misperceptions related to PN compatibility to ensure patient safety.
  • Bridge evidence and practice to identify PN dosing strategies that mitigate metabolic complications.

 

This is a non-promotional education program not accredited for continuing education and free for all.

Baxter

Topics & Presenters

Camilia Martin
MD, MS

Division Chief of Neonatology

Weill Cornell, New York

New York, NY
Emma Ross
PharmD, BCPPS

Neonatal Clinical Pharmacy Specialist

Children’s Hospital Colorado

Aurora, CO
Stephanie Merlino Barr
PhD, RDN, LD

Neonatal Dietitian

Neonatal Intensive Care Unit, MetroHealth

Cleveland, OH

Corporate Symposium: Short Bowel, Long Journey: Managing Parenteral Nutrition in Complex Adult Patients from ICU to Home (SYMP1)

Corporate Event

Date & Time:

February 15, 2026

6:00 AM – 7:30 AM PT

Format:

In Person & Virtual

session objectives:

What You'll Learn

  • Identify key clinical indicators for initiating PN in critically ill adult surgical patients. 
  • Apply advanced nutrition assessment techniques to guide PN formulation and dosing among adults. 
  • Evaluate strategies to prevent PN-related complications among adults in both inpatient and home settings. 
  • Understand the interdisciplinary roles of physicians, dietitians, and pharmacists in PN management using various strategies to optimize individualized nutrition support outcomes. 


This is a non-promotional education program not accredited for continuing education and free for all.

Baxter

Topics & Presenters

Lindsey Russell
MD, MSc, CNSC, FRCPC

Gastroenterologist

Digestive Disease and Surgery Institute, Cleveland Clinic

Cleveland, OH
Christan Bury
MS, RD, LD, CNSC

Advanced Practice II Dietitian

Digestive Disease and Surgery Institute, Cleveland Clinic

Cleveland, OH
Sarah Cogle
PharmD, BCCCP, BCNSP, FCCM, FASPEN

Clinical Pharmacist Specialist and Team Lead

Burn Critical Care/Nutrition Support, Vanderbilt University Medical Center

Nashville, TN

Corporate Symposium: Advancing Parenteral Nutrition (PN): Alternative Lipids, PN, and Supplemental PN, and Multi-Chamber Bag PN Safety (SYMP3)

Corporate Event

Date & Time:

February 16, 2026

6:00 AM – 7:30 AM PT

Format:

In Person & Virtual

session objectives:

What You'll Learn

This session will explore innovations and safety strategies in parenteral nutrition, emphasizing the clinical role of alternative lipid sources. Speakers will share actionable strategies and best practices for the use of alternative lipids in nutrition, PN’s place in clinical therapy, and best practices for multi-chamber bag PN.

Upon completion of the program, participants will be able to:

  • Outline the types of alternative lipid sources available for parenteral nutrition and their clinical applications, benefits, and considerations in patient care.
  • Describe the role of supplemental and parenteral nutritional management of patients.
  • Explain the place in therapy and steps to safely implement use of multi-chamber bag parenteral nutrition.

CE Accreditation

Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by Partners for Advancing Clinical Education (Partners) and Institute for Safe Medication Practices.  Partners is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Education
Partners designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Professional Development
The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 1.5 ANCC contact hours.

Pharmacy Continuing Education
Partners designates this continuing education activity for 1.5 contact hour(s) (0.15 CEUs) of the Accreditation Council for Pharmacy Education.
(Universal Activity Number –  JA4008073-9999-26-045-L05-P/T)
Type of Activity: Application

Dietitian Continuing Education
This program offers 1.5 CPEUs for dieticians.

Interprofessional Continuing Education

This activity was planned by and for the healthcare team, and learners will receive 1.5 Interprofessional Continuing Education (IPCE) credit for learning and change.

Funding Source: This activity is supported by an independent educational grant from Fresenius Kabi.

Topics & Presenters

Manpreet Mundi
MD, FASPEN

Professor of Medicine

Division of Endocrinology, Diabetes, Metabolism, and Nutrition, Mayo Clinic

Rochester, MN
Angela Bingham
PharmD

Chair

Department of Pharmacy Practice, Philadelphia College of Pharmacy at Saint Joseph's University

PharmD Program Director

Department of Pharmacy Practice, Philadelphia College of Pharmacy at Saint Joseph's University

Clinical Professor

Department of Pharmacy Practice, Philadelphia College of Pharmacy at Saint Joseph's University

Philadelphia, PA
Christina Michalek
BS, RPh

Director, Membership & PSO

ISMP

Plymouth Meeting, PA

Corporate Symposium: From Survival to Recovery: Rebuilding Metabolism After Critical Illness

Corporate Event

Date & Time:

February 16, 2026

6:00 AM – 7:30 AM PT

Format:

In Person

session objectives:

What You'll Learn

Discover how critical illness impacts nutrient absorption and metabolism, learn the latest on omega-3 fatty acids and specialized pro-resolving mediators in reducing inflammation, and discuss post-intensive care syndrome (PICS) including its effect on long-term outcomes.  The panel will address practical nutrition strategies to support recovery while providing clinicians with actionable insights to optimize care across the continuum of critical illness.

  • Distinguish malabsorption, feeding intolerance, and inadequate caloric delivery in the critically ill patient.
  • Review the importance of omega 3 PUFAs and SPMs in “resolution” pathways as novel therapeutic strategies
  • Define characteristics and consequences of post-intensive care syndrome (PICS).

 

Accreditation Information:

Financial Support provided by Nestlé Health Science

For Dietitians: Funding from non-CPE revenue for CPE planning, development, review, and/or presentation has been provided by Nestlé Health Science.
From Survival to Recovery: Rebuilding Metabolism After Critical Illness awards 1.5 CPEUs in accordance with the Commission on Dietetic Registration’s CPEU Prior Approval Program. Provider Number NE008.

1.5 contact hours are available for Registered Nurses. Nestlé Health Science is a Continuing Education Provider approved by the California Board of Registered Nursing; Provider Number 11366.

There is no charge for participating in this program.

By your participation in this event, you are declaring that your participation is in compliance with the laws of your state and presents no conflict of interest with your facility’s policies and procedures.

Pre-registration for this event is strongly encouraged. Please note this is an in-person event only. 
This site is unable to accept pre-registration from NON-US attendees. International attendees will need to check in with an event staff member on the morning of the event.

Topics & Presenters

Jayshil Patel
MD, FASPEN

Associate Professor of Medicine

Division of Pulmonary and Critical Care Medicine, Medical College of Wisconsin

Milwaukee, Wi
Robert Martindale
MD, PhD, FASPEN

Professor of Surgery

Division of Gastrointestinal and General Surgery, Oregon Health & Science University

Medical Director

Hospital Nutrition Services, Oregon Health & Science University

Portland, OR
Beth Taylor
DCN, RD-AP, FASPEN, FCCM

Research Scientist

Barnes-Jewish Hospital

St. Louis, MO